Daily Stock Analysis, ADMA, ADMA Biologics Inc, priceseries

ADMA Biologics Inc. Daily Stock Analysis
Stock Information
Open
3.16
Close
3.32
High
3.32
Low
3.15
Previous Close
3.25
Daily Price Gain
0.07
YTD High
5.79
YTD High Date
Jan 9, 2017
YTD Low
2.67
YTD Low Date
Aug 21, 2017
YTD Price Change
-1.66
YTD Gain
-33.33%
52 Week High
7.70
52 Week High Date
Sep 27, 2016
52 Week Low
2.67
52 Week Low Date
Aug 21, 2017
52 Week Price Change
-4.03
52 Week Gain
-54.83%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Oct 5. 2015
9.00
Oct 21. 2015
9.60
12 Trading Days
6.65%
Link
LONG
Mar 17. 2016
5.13
Apr 7. 2016
7.56
14 Trading Days
47.36%
Link
LONG
Sep 15. 2016
5.65
Oct 5. 2016
6.94
14 Trading Days
22.76%
Link
Company Information
Stock Symbol
ADMA
Exchange
NasdaqCM
Company URL
http://http://www.admabiologics.com
Company Phone
(201) 478-5552
CEO
Adam S. Grossman
Headquarters
New Jersey
Business Address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ 07446
Sector
Equity
Industry Category
Drugs
Industry Group
Biotechnology
CIK
0001368514
About

ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases.

Description

ADMA Biologics, Inc., a late stage biopharmaceutical company, develops, manufactures, and intends to market specialty plasma-based biologics for the treatment and prevention of infectious diseases. Its lead product candidate is RI-002, a plasma-derived, polyclonal immune globulin intravenous that is in Phase III clinical study for the treatment of primary immune deficiency disease. The company also operatesADMA BioCenters Georgia, Inc, which is a plasma collection center. ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey.